Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate the disease within years.

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus vaccine. Rates of precancerous lesions in women between

The human papillomavirus (HPV) vaccine is having a huge impact on cervical cancer prevention among young women, a U.S. government report published Thursday suggests. Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer dropped by about 80% from 2008 to 2022.